Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LTBI Screening and Treatment in Prison
NCT00767975Phase 3Completed
- Sponsor
- National Taiwan University Hospital
- Start
- Jan 2008
- Primary completion
- Nov 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of isoniazid, rifampicin in Tuberculosis (TB), sponsored by National Taiwan University Hospital. Started Jan 2008; status: completed.
02
Drugs
isoniazidrifampicin
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT00767975.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00767975.